» Articles » PMID: 34555955

Factors Associated with Decision Making on COVID-19 Vaccine Acceptance Among College Students in South Carolina

Overview
Publisher Routledge
Date 2021 Sep 24
PMID 34555955
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

COVID-19 vaccination could be a promising approach in controlling the pandemic, but its success relies on the vaccine acceptance among various populations including young adults who are vulnerable to COVID-19 due to active lifestyle and perceived invulnerability. Vaccine acceptance decisions can be influenced by multiple factors and people may weigh these factors differently in decision making. The current study aimed to explore COVID-19 vaccine acceptance among college students in South Carolina and examine how they weigh these factors according to their COVID-19 vaccine acceptance levels (i.e. acceptance, hesitance, refusal). Online survey data were collected from 1062 college students in South Carolina between September and October 2020. Multinomial logistic regresssion was used to compare perceived importance of 12 factors affecting levels of vaccine acceptance, controlling for demographic variables. About 26.1% of participants reported they would definitely take COVID-19 vaccines when available. Compared to acceptance group, refusal and hesitance groups considered side effects and vaccine characteristics (e.g. where the vaccine is produced) as important. Hesitance group considered authoritative advice from school/college as important. Acceptance group considered authoritative advice from government/doctors and local availability of the vaccines and local availability of the vaccines as important. Our findings suggest relatively low vaccine acceptance among college students in South Carolina and different factors were considered in their vaccination decision according to their acceptance levels. Tailored vaccine promotion messages should address specific concerns among the refusal and hesitancy groups. Schools should attend to valid communication strategies in vaccine campaign since the hesitancy group considered school's advice as important. College health educators also need to pay attention to the refusal group who do not value duration of protection or authoritative advice as much as their counterparts in vaccine decision making.

Citing Articles

Prevalence of COVID-19 vaccine hesitancy in students: A global systematic review.

Nath Roy D, Hossen M, Biswas M, Islam E, Azam M F1000Res. 2024; 11:928.

PMID: 39290373 PMC: 11406128. DOI: 10.12688/f1000research.122815.1.


Evaluating COVID-19 infection prevention measures in Malaysia: A fuzzy DEMATEL approach.

Yadegaridehkordi E, Nilashi M, Nizam Bin Md Nasir M, Safie Bin Mohd Satar N, Momtazi S Digit Health. 2023; 9:20552076231211670.

PMID: 38074341 PMC: 10702419. DOI: 10.1177/20552076231211670.


Parents' Trust in COVID-19 Messengers and Implications for Vaccination.

Klein L, Habib D, Edwards L, Hager E, Berry A, Connor K Am J Health Promot. 2023; 38(3):364-374.

PMID: 37766398 PMC: 11332662. DOI: 10.1177/08901171231204480.


Role of Trust, Risk Perception, and Perceived Benefit in COVID-19 Vaccination Intention of the Public.

Man S, Wen H, Zhao L, So B Healthcare (Basel). 2023; 11(18).

PMID: 37761786 PMC: 10530888. DOI: 10.3390/healthcare11182589.


Association between health and safety perceptions of COVID-19 vaccine and its uptake in Ghana.

Aram S, Hagan Jr J, Mansoh G, Saalidong B, Lartey P, Ahinkorah B Public Health Chall. 2023; 1(4):e20.

PMID: 37519313 PMC: 9874404. DOI: 10.1002/puh2.20.


References
1.
Reiter P, Pennell M, Katz M . Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?. Vaccine. 2020; 38(42):6500-6507. PMC: 7440153. DOI: 10.1016/j.vaccine.2020.08.043. View

2.
Muric G, Wu Y, Ferrara E . COVID-19 Vaccine Hesitancy on Social Media: Building a Public Twitter Data Set of Antivaccine Content, Vaccine Misinformation, and Conspiracies. JMIR Public Health Surveill. 2021; 7(11):e30642. PMC: 8694238. DOI: 10.2196/30642. View

3.
Stringhini S, Wisniak A, Piumatti G, Azman A, Lauer S, Baysson H . Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020; 396(10247):313-319. PMC: 7289564. DOI: 10.1016/S0140-6736(20)31304-0. View

4.
Poehling K, Blocker J, Ip E, Peters T, Wolfson M . 2009-2010 seasonal influenza vaccination coverage among college students from 8 universities in North Carolina. J Am Coll Health. 2012; 60(8):541-7. PMC: 3507424. DOI: 10.1080/07448481.2012.700973. View

5.
Lazarus J, Ratzan S, Palayew A, Gostin L, Larson H, Rabin K . A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2020; 27(2):225-228. PMC: 7573523. DOI: 10.1038/s41591-020-1124-9. View